Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
Alison Simmons
Director
Research Interests
Explore related searches
Articles (15)
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Summary T cell recognition of SARS-CoV-2 antigens after vaccination and/or natural infection has played a central role in resolving SARS-CoV-2 infections and generating adaptive immune memory. However, the clinical impact of SARS-CoV-2-specific T cell responses is variable and the mechanisms underlying T cell interaction with target antigens are not fully understood. This is especially true given the virus’ rapid evolution, which leads to new variants with immune escape capacity. In this study, we used the Omicron variant as a model organism and took a systems approach to evaluate the impact of mutations on CD8+ T cell immunogenicity. We computed an immunogenicity potential score for each SARS-CoV-2 peptide antigen from the ancestral strain and Omicron, capturing both antigen presentation and T cell recognition probabilities. By comparing ancestral vs. Omicron immunogenicity scores, we reveal a divergent and heterogeneous landscape of impact for CD8+ T cell recognition of mutated targets in Omicron variants. While T cell recognition of Omicron peptides is broadly preserved, we observed mutated peptides with deteriorated immunogenicity that may assist breakthrough infection in some individuals. We then combined our scoring scheme with an in silico mutagenesis, to characterise the position- and residue-specific theoretical mutational impact on immunogenicity. While we predict many escape trajectories from the theoretical landscape of substitutions, our study suggests that Omicron mutations in T cell epitopes did not develop under cell-mediated pressure. Our study provides a generalisable platform for fostering a deeper understanding of existing and novel variant impact on antigen-specific vaccine- and/or infection-induced T cell immunity.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (21)
Laura Stronati
Full Professor
Sapienza University of Rome
Kevin Monahan
Imperial College London
Chloe H. Lee
University of Oxford
Semir Beyaz
Principal Investigator
Cold Spring Harbor Laboratory
Lori Coburn
Associate Professor
Vanderbilt University Medical Center
David Ellinghaus
Professor
Kiel University
Zoe Christoforidou
University of Oxford
James Lee
The Francis Crick Institute
Walter Bodmer
Laboratory Head
University of Oxford
Calliope A Dendrou
Associate Professor in Clinical Pathology and Inflammation
University of Oxford
Michel Georges
University of Liege
Jose Ordovas-Montanes
Research Faculty
Boston Children's Hospital
Hashem Koohy
University of Oxford
Martin Fellermeyer
University of Oxford
Christian Tomuschat
University Medical Center Hamburg-Eppendorf
Gordon Moran
University of Nottingham
Britta F. Zecher
University Medical Center Hamburg-Eppendorf
Craig Mowat
Clinical Senior Lecturer
University of Dundee
Debby Laukens
Associate Professor
Ghent University
Tarun Gupta
NIHR Academic Clinical Lecturer in Gastroenterology
Weatherall Institute of Molecular Medicine
Mauro D'Amato
Professor of Medical Gentics
LUM Jean Monnet University
Make your next move.
Prepare your application
Review drafts before you send them.